Cardiac sarcoidosis is a rare and often underdiagnosed condition characterized by the presence of inflammatory cells, known as granulomas, within the heart tissue. Sarcoidosis itself is a multisystem inflammatory disorder that can affect various organs, but when it involves the heart, it becomes particularly challenging due to the potential for serious complications. The exact cause of cardiac sarcoidosis remains unclear, but it is believed to involve an abnormal immune response. Symptoms can vary widely and may include arrhythmias, heart failure, and conduction abnormalities. Diagnosing cardiac sarcoidosis can be complex, often requiring a combination of clinical evaluation, imaging studies such as cardiac MRI or PET scans, and occasionally, cardiac biopsy. Timely diagnosis is crucial, as cardiac sarcoidosis can lead to significant morbidity and mortality if left untreated. Treatment often includes the use of immunosuppressive medications, which are prescribed to mitigate inflammation and alleviate symptoms. Given the rarity of the condition, increased awareness and collaboration between cardiologists and other specialists are essential for improving the early detection and management of cardiac sarcoidosis.
Title : Novel mechanisms and new therapeutics for right heart failure in pulmonary hypertension
Yong Xiao Wang, Albany Medical College, United States
Title : Movement is medicine
Steve Cohen, Medvesta Hypnosis Healthcare, United States
Title : Historical evolution from OPCAB to MIDCAB to mini OPCAB surgical technique and results
Federico Benetti, Benetti Foundation, Argentina
Title : Fats of life, the skinny on novel lipid therapies beyond statins
Ahdy Wadie Helmy, Indiana University School of Medicine, United States
Title : Novel ways of cardiovascular risk assessment
Syed Raza, Awali Hospital, Bahrain
Title : Cardiovascular nanomedicine: Stopping strokes, unclogging arteries and restoring heart function
Thomas J Webster, Hebei University of Technology, China